Skip to main content

Closed

LNAI: Lunai Bioworks Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin-46992.0%

ROIC120.9%

Financially safe

Stretched

Debt / equity-0.15×

Interest coverage-16.2×

Current ratio0.19×

Lunai Bioworks Inc.

LNAINASDAQ Global Market·USD·Closed

Lunai Bioworks Inc.

LNAINASDAQ·USD·Closed

$1.94

−3.96%

$1.94

−$0.08 (3.96%)

52W Range

4thpctl

Volume

0.02×avg

Mkt Cap

8.80MUSD

P/E

-0.0TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.02×avg

Market Cap

8.80MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings